High dose therapy and autologous hematopoietic stem cell transplantation in septuagenarians with non-Hodgkin lymphoma: Feasible, but for which patients?-Reference-Cited by-同舟云学术

High dose therapy and autologous hematopoietic stem cell transplantation in septuagenarians with non-Hodgkin lymphoma: Feasible, but for which patients?

Published:2015-09 Issue:5 Volume:6 Page:344-345
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Wildes Tanya M.^ORCID,Cashen Amanda

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference11 articles.

1. Impact of age on outcome of patients with cancer undergoing autologous bone marrow transplant;Miller;J Clin Oncol,1996

2. Autologous hematopoietic stem cell transplantation in elderly patients (≥70years) with non-Hodgkin's lymphoma: a French Society of Bone Marrow Transplantation and Cellular Therapy retrospective study;Hermet;J Geriatr Oncol,2015

3. Sorror ML, Logan BR, Zhu X, Rizzo JD. Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A CIBMTR® Study. Biology of Blood and … 2015.

4. Risk factors for a poor hematopoietic stem cell mobilization;Donmez;Transfus Apher Sci,2013

5. Predictors of unsuccessful mobilization with granulocyte colony-stimulating factor alone in patients undergoing autologous hematopoietic stem cell transplantation;Chow;J Clin Apher,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radioimmunotherapy-based conditioning regimen prior to autologous stem cell transplantation in non-Hodgkin lymphoma;International Journal of Hematologic Oncology;2018-03-01